Skip to main content

Table 4 Logistic regression model to predict the presence of acute ischemic stroke in relation to prevalence of KIR haplotypes

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

Variable Beta Exp(B) 95% confidence interval for Exp(B) p value
HLA-A-Bw4 0.16 1.18 0.42–3.26 0.745
HLA-A aplotype 0.17 1.19 0.48–2.9 0.702
HLA-C1 0.09 1.09 0.35–3.4 0.874
HLA-C2 0.55 1.73 0.53–5.69 0.361
HLA-B-Bw4T 0.30 1.35 0.44–4.11 0.593
HLA-B-Bw4I − 3.64 0.02 0.008–0.08 < 0.0001
2DL2-HLA-C1 − 1.90 0.149 0.041–0.55 0.004
2DL3-HLA-C1 0.32 1.37 0.50–3.75 0.529
2DS2-HLA-C1 0.68 1.97 0.67–5.83 0.216
2DS2-HLA-C2 2.68 14.68 2.33–92.4 0.004
2DL2-HLA-C2 0.13 1.14 0.34–3.84 0.825
2DS1-HLA-C2 − 0.27 0.75 0.21–2.64 0.667
2DL1-HLA-C1 0.37 1.45 0.34–6.07 0.607
2DL2-HLA-C1_A 1.84 6.33 1.46–27.47 0.014
2DL1-HLA-C2 0.03 1.03 0.30–3.59 0.953
  1. KIR killer cell immunoglobulin-like receptor, HLA human leukocyte antigen